Part I: IMMUNOLOGY AND TARGETING CONSTRUCTS
1: The Immune System
2: Methods for Development of Monoclonal Antibody Therapeutics
3: Peptides
4: Affibody Molecules for Targeted Radionuclide Therapy
5: Aptamers
Part II: PHYSICS AND RADIOBIOLOGY OF TRT
6: The Physics and Radiobiology of TRT
7: Chelation Chemistry
8: Radiation Dosimetry
9: Microdosimetry
10: Radiation Safety for RT
Part III: TUMOR MICROENVIRONMENT AND DELIVERY STRATEGIES
11: Employing SEREX
12: Antibody Penetration into Tumors
13: Overcoming Barriers Posed by Solid Tumors
14: The Delivery Construct
15: The Type of Radionuclide
16: Pretargeting Strategies for TRT
17: Combined Modality Strategies
18: Extracorporeal Techniques
19: Concept of Systemic Therapy
20: Modeling of the Systemic Cure with TRT
Part IV: UNCONJUGATED THERAPY
21: Thyroid Cancer
22: Unconjugated Radiopharmaceuticals
23: 90-y Microspheres
24: SIRT
Part V: CONJUGATED THERAPY
25: Colorectal Cancer
26: Pancreatic Cancer
27: Hepatobillary Cancer
28: Astrocytoma
29: Medullary Thyroid Cancer
30: Head and Neck Cancer
31: Prostate Cancer
32: Renal Cell Carcinoma
33: Bladder Cancer
34: Leukemia
35: Non-Hodgkin's Lymphoma
36: Hodgkin's Disease
37: Multiple Myeloma
38: Neuroendocrine Tumors
39: Malignancies Treated with Peptides
40: Ovarian Cancer
41: Osteosarcoma
42: Pediatric Tumors
43: Palliation
44: Melanoma
|